EGFR and cancer: To test this, we aimed to prevent EGFR S-glutathionylation in cancer cells by inhibition of glutathione S-transferase P1 (GSTP1), a known catalyst of protein S-glutathionylation30 and a potential direct substrate for phosphorylation and activation by EGFR31.